NANOG and cancer: Treatment with α-mangostin, Man-3DG, and Man-6DG markedly decreased the expression levels of cancer stemness regulators, including Nanog, Oct4, Sox2, CD44, and CD133, in the 3D tumorsphere-cultured Hep3B cells (Figure 10D).